Medtronic PLC Company Insiders
MDT Stock | USD 91.87 0.34 0.37% |
Slightly above 91 percent of Medtronic PLC's insiders are activelly selling. The analysis of insiders' sentiment of trading Medtronic PLC stock suggests that a very large number of insiders are panicking at this time. Medtronic PLC employs about 95 K people. The company is managed by 47 executives with a total tenure of roughly 242 years, averaging almost 5.0 years of service per executive, having 2021.28 employees per reported executive.
Omar Ishrak Chairman Chairman of the Board, Chief Executive Officer |
Bradley Lerman President Senior Vice President General Counsel, Corporate secretary |
Insider Sentiment 9
Mostly Selling
Selling | Buying |
Latest Trades
2025-01-24 | Brett A Wall | Disposed 12437 @ 90 | View | ||
2025-01-08 | Brett A Wall | Disposed 9850 @ 80.41 | View | ||
2025-01-06 | Emily Randall | Disposed @ 79.77 | |||
2024-09-04 | John James | Disposed @ 91.03 | |||
2024-08-26 | Tommy Tuberville | Disposed @ 89.34 | |||
2024-07-09 | Earl Blumenauer | Disposed @ 76.89 | |||
2024-07-02 | Kathy E. Manning | Disposed @ 77.37 | |||
2024-06-18 | John James | Acquired @ 79.75 | |||
2024-06-07 | Geoffrey Martha | Disposed 19113 @ 83.77 | View | ||
2024-06-03 | John James | Disposed @ 82.12 | |||
2024-04-08 | Michael Marinaro | Disposed 854 @ 83.14 | View |
Monitoring Medtronic PLC's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Medtronic PLC's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Medtronic PLC. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Medtronic PLC's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Medtronic |
Medtronic PLC's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Medtronic PLC's future performance. Based on our forecasts, it is anticipated that Medtronic will maintain a workforce of slightly above 95000 employees by April 2025.Medtronic PLC's latest congressional trading
Congressional trading in companies like Medtronic PLC, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Medtronic PLC by those in governmental positions are based on the same information available to the general public.
2025-02-12 | Representative Emily Randall | Acquired Under $15K | Verify | ||
2024-12-06 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
2024-09-12 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
2024-09-06 | Representative John James | Acquired Under $15K | Verify | ||
2024-09-02 | Representative John James | Acquired Under $15K | Verify | ||
2024-08-16 | Representative Kathy Manning | Acquired Under $15K | Verify | ||
2024-03-15 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
2024-03-14 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
2023-12-14 | Representative Debbie Dingell | Acquired $15K to $50K | Verify | ||
2023-06-26 | Representative Pete Sessions | Acquired $15K to $50K | Verify | ||
2023-04-19 | Senator Tina Smith | Acquired $100K to $250K | Verify | ||
2023-04-18 | Senator Tina Smith | Acquired $100K to $250K | Verify | ||
2022-12-22 | Representative Bob Gibbs | Acquired $15K to $50K | Verify | ||
2022-08-07 | Representative Alan S Lowenthal | Acquired Under $15K | Verify | ||
2022-08-04 | Representative Alan S Lowenthal | Acquired Under $15K | Verify | ||
2022-06-12 | Senator Roy Blunt | Acquired $15K to $50K | Verify | ||
2022-05-05 | Representative William R Keating | Acquired Under $15K | Verify | ||
2021-05-25 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
2020-11-04 | Representative Alan S Lowenthal | Acquired Under $15K | Verify | ||
2020-04-10 | Representative Peter Welch | Acquired Under $15K | Verify | ||
2019-02-28 | Representative Katherine M Clark | Acquired Under $15K | Verify | ||
2016-10-04 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
2016-10-03 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
2015-02-25 | Senator Gary Peters | Acquired $15K to $50K | Verify | ||
2015-02-24 | Senator Gary Peters | Acquired $15K to $50K | Verify |
Medtronic PLC Management Team Effectiveness
The company has Return on Asset of 0.0466 % which means that on every $100 spent on assets, it made $0.0466 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0844 %, implying that it generated $0.0844 on every 100 dollars invested. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.18 in 2025, whereas Return On Capital Employed is likely to drop 0.05 in 2025. Total Current Liabilities is likely to gain to about 13 B in 2025. Liabilities And Stockholders Equity is likely to gain to about 108.7 B in 2025Medtronic PLC Quarterly Income Before Tax |
|
Medtronic PLC Workforce Comparison
Medtronic PLC is regarded second in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 385,495. Medtronic PLC totals roughly 95,000 in number of employees claiming about 25% of equities under Health Care industry.
Medtronic PLC Profit Margins
The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.22 %, which entails that for every 100 dollars of revenue, it generated $0.22 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.8 | 0.6519 |
|
| |||||
Net Profit Margin | 0.18 | 0.1197 |
|
| |||||
Operating Profit Margin | 0.25 | 0.1489 |
|
| |||||
Pretax Profit Margin | 0.24 | 0.1293 |
|
| |||||
Return On Assets | 0.0368 | 0.0387 |
|
| |||||
Return On Equity | 0.0666 | 0.0701 |
|
|
Medtronic PLC Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medtronic PLC insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medtronic PLC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Medtronic PLC insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-03-01 | 1.0 | 12 | 12 | 170,712 | 114,003 |
2024-09-01 | 1.0278 | 37 | 36 | 1,337,156 | 177,078 |
2024-06-01 | 0.75 | 12 | 16 | 40,419 | 49,227 |
2024-03-01 | 0.375 | 3 | 8 | 30,695 | 63,112 |
2023-12-01 | 0.1667 | 1 | 6 | 1,695 | 8,904 |
2023-09-01 | 1.4643 | 41 | 28 | 1,239,904 | 164,405 |
2023-06-01 | 0.7143 | 10 | 14 | 18,994 | 16,519 |
2022-12-01 | 0.375 | 3 | 8 | 19,035 | 42,453 |
2022-09-01 | 2.6364 | 29 | 11 | 992,938 | 141,741 |
2022-06-01 | 0.75 | 9 | 12 | 15,273 | 41,856 |
2022-03-01 | 1.5 | 6 | 4 | 263,528 | 18,441 |
2021-12-01 | 0.5833 | 7 | 12 | 114,310 | 109,034 |
2021-09-01 | 2.0833 | 50 | 24 | 954,577 | 353,536 |
2021-06-01 | 0.7241 | 21 | 29 | 85,734 | 127,976 |
2021-03-01 | 1.3333 | 4 | 3 | 30,408 | 14,968 |
2020-12-01 | 0.8333 | 20 | 24 | 299,479 | 187,592 |
2020-09-01 | 2.2 | 44 | 20 | 1,544,886 | 123,375 |
2020-06-01 | 0.8125 | 13 | 16 | 41,996 | 31,360 |
2019-12-01 | 0.463 | 25 | 54 | 463,606 | 712,142 |
2019-09-01 | 0.9111 | 41 | 45 | 1,237,216 | 334,070 |
2019-06-01 | 0.88 | 22 | 25 | 79,895 | 139,562 |
2019-03-01 | 1.0 | 3 | 3 | 17,671 | 8,227 |
2018-12-01 | 2.0 | 2 | 1 | 20,139 | 1,698 |
2018-09-01 | 1.1944 | 43 | 36 | 1,398,013 | 675,883 |
2018-06-01 | 0.6296 | 17 | 27 | 385,289 | 2,853,878 |
2018-03-01 | 0.5 | 7 | 14 | 157,732 | 330,011 |
2017-09-01 | 1.5 | 33 | 22 | 911,933 | 348,255 |
2017-06-01 | 1.0909 | 12 | 11 | 28,590 | 13,522 |
2017-03-01 | 0.6667 | 12 | 18 | 211,678 | 425,457 |
2016-12-01 | 0.6667 | 2 | 3 | 15,660 | 26,773 |
2016-09-01 | 1.3158 | 50 | 38 | 1,089,286 | 406,548 |
2016-06-01 | 0.8462 | 22 | 26 | 156,455 | 145,741 |
2016-03-01 | 0.1538 | 2 | 13 | 324,506 | 677,717 |
2015-12-01 | 0.25 | 1 | 4 | 15,401 | 40,665 |
2015-09-01 | 2.0 | 32 | 16 | 839,875 | 145,854 |
2015-06-01 | 3.8571 | 27 | 7 | 61,114 | 135,272 |
2015-03-01 | 1.8081 | 179 | 99 | 6,014,655 | 1,992,706 |
2014-12-01 | 0.3 | 3 | 10 | 2,581 | 89,399 |
2014-09-01 | 2.0667 | 31 | 15 | 535,650 | 106,643 |
2014-06-01 | 1.8333 | 11 | 6 | 25,489 | 11,004 |
2013-12-01 | 1.3333 | 4 | 3 | 99,702 | 40,928 |
2013-09-01 | 0.96 | 24 | 25 | 360,989 | 398,990 |
2013-06-01 | 1.1875 | 19 | 16 | 204,068 | 378,387 |
2012-12-01 | 3.5 | 7 | 2 | 15,566 | 38,196 |
2012-09-01 | 2.4 | 12 | 5 | 429,430 | 17,440 |
2012-03-01 | 0.75 | 3 | 4 | 59,962 | 118,702 |
2011-12-01 | 0.0667 | 1 | 15 | 1,248 | 38,798 |
2011-09-01 | 1.2143 | 17 | 14 | 598,918 | 62,618 |
2011-06-01 | 9.0 | 9 | 1 | 49,273 | 380.00 |
2010-12-01 | 0.25 | 2 | 8 | 101,348 | 39,806 |
2010-09-01 | 5.0 | 20 | 4 | 895,815 | 12,364 |
2010-06-01 | 4.0 | 20 | 5 | 91,400 | 8,127 |
2010-03-01 | 0.6 | 3 | 5 | 43,708 | 11,844 |
2009-12-01 | 0.6429 | 9 | 14 | 127,612 | 66,635 |
2009-09-01 | 5.3333 | 16 | 3 | 673,724 | 1,085 |
2009-06-01 | 5.3333 | 16 | 3 | 40,521 | 7,652 |
2008-12-01 | 1.9091 | 21 | 11 | 766,832 | 38,424 |
2008-09-01 | 1.3333 | 8 | 6 | 160,896 | 16,205 |
2008-06-01 | 1.6111 | 29 | 18 | 143,217 | 141,362 |
2008-03-01 | 66.0 | 66 | 1 | 255,093 | 1,504 |
2007-12-01 | 1.9167 | 23 | 12 | 607,954 | 61,661 |
2007-09-01 | 1.6 | 24 | 15 | 610,305 | 1,020,372 |
2007-06-01 | 1.0541 | 39 | 37 | 149,614 | 66,887 |
2007-03-01 | 0.4091 | 9 | 22 | 42,773 | 76,943 |
2006-12-01 | 1.6667 | 25 | 15 | 666,270 | 198,298 |
2006-09-01 | 5.8333 | 35 | 6 | 144,798 | 89,128 |
2006-06-01 | 1.2308 | 16 | 13 | 183,923 | 18,197 |
2006-03-01 | 1.6667 | 5 | 3 | 23,099 | 33,592 |
2005-12-01 | 1.0 | 13 | 13 | 594,379 | 16,345 |
2005-09-01 | 2.25 | 27 | 12 | 103,113 | 187,418 |
2005-06-01 | 1.0 | 37 | 37 | 387,841 | 526,488 |
2005-03-01 | 0.4 | 2 | 5 | 9,776 | 19,552 |
2004-12-01 | 0.6 | 15 | 25 | 704,443 | 163,573 |
2004-09-01 | 1.9231 | 25 | 13 | 217,468 | 368,876 |
2004-06-01 | 1.3571 | 19 | 14 | 129,092 | 11,360 |
2004-03-01 | 0.2308 | 3 | 13 | 90,555 | 219,094 |
2003-12-01 | 0.6111 | 11 | 18 | 639,406 | 153,766 |
2003-09-01 | 15.0 | 30 | 2 | 234,817 | 10,895 |
2003-06-01 | 0.0938 | 3 | 32 | 43,992 | 389,797 |
Medtronic PLC Notable Stakeholders
A Medtronic PLC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medtronic PLC often face trade-offs trying to please all of them. Medtronic PLC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medtronic PLC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Omar Ishrak | Chairman of the Board, Chief Executive Officer | Profile | |
Bradley Lerman | Senior Vice President General Counsel, Corporate secretary | Profile | |
Ryan Weispfenning | Vice President - Investor Relations | Profile | |
Hooman Hakami | Executive Vice President and Group President of the Medtronic Diabetes Group | Profile | |
Richard Kuntz | Senior Vice President and Chief Scientific, Clinical and Regulatory Officer | Profile | |
Robert White | Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group | Profile | |
Frank Chan | President Monitoring | Profile | |
Sean Salmon | Executive Vice President and President, Diabetes Operating Unit, President, Cardiovascular Portfolio | Profile | |
Carol Surface | Chief Human Resource Officer, Senior Vice President | Profile | |
Karen Parkhill | Chief Financial Officer, Executive Vice President | Profile | |
Geoffrey Martha | Executive Vice President and President - Restorative Therapies Group | Profile | |
Robert Hoedt | Executive Vice President and President - EMEA Region | Profile | |
Michael Coyle | Executive Vice President, Group President - Cardiac and Vascular Group | Profile | |
Scott Donnelly | Lead Independent Director | Profile | |
Richard Anderson | Lead Independent Director | Profile | |
Elizabeth Nabel | Independent Director | Profile | |
James Lenehan | Independent Director | Profile | |
Craig Arnold | Independent Director | Profile | |
Kendall Powell | Lead Independent Director | Profile | |
Denise OLeary | Independent Director | Profile | |
Michael Leavitt | Independent Director | Profile | |
Randall Hogan | Independent Director | Profile | |
Andrea Goldsmith | Independent Director | Profile | |
Joon Hurh | VP Pacific | Profile | |
Ivan Fong | General VP | Profile | |
Ivan JD | General VP | Profile | |
Brett Wall | Executive Vice President and President Restorative Therapies Group | Profile | |
Jennifer Kirk | Chief Accounting Officer, Global Controller | Profile | |
Scott Cundy | Senior Officer | Profile | |
Kenneth Washington | Senior Officer | Profile | |
Mark Ploof | Senior Services | Profile | |
Sean Lennon | Chief Officer | Profile | |
Mei Jiang | Senior Innovation | Profile | |
John Liddicoat | Executive Vice President and President Americas Region | Profile | |
Kevin Lofton | Independent Director | Profile | |
Olaf Hedrich | Chief Officer | Profile | |
Sally Saba | Chief Inclusion and Diversity Officer | Profile | |
Brad Lerman | Senior Vice President General Counsel, Corporate secretary | Profile | |
Matt Walter | Chief Officer | Profile | |
Torod Neptune | Senior Officer | Profile | |
Thierry Pieton | Chief Officer | Profile | |
Gary Corona | Senior Finance | Profile | |
Que Dallara | Executive Unit | Profile | |
Gregory Smith | Executive Chain | Profile | |
Robert Hopkins | Senior Strategy | Profile | |
MSc MD | Medical Scientific | Profile | |
MPH MD | Chief Business | Profile |
About Medtronic PLC Management Performance
The success or failure of an entity such as Medtronic PLC often depends on how effective the management is. Medtronic PLC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medtronic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medtronic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.11 | 0.18 | |
Return On Capital Employed | 0.05 | 0.05 | |
Return On Assets | 0.04 | 0.04 | |
Return On Equity | 0.07 | 0.07 |
Please note, the imprecision that can be found in Medtronic PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medtronic PLC. Check Medtronic PLC's Beneish M Score to see the likelihood of Medtronic PLC's management manipulating its earnings.
Medtronic PLC Workforce Analysis
Traditionally, organizations such as Medtronic PLC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medtronic PLC within its industry.Medtronic PLC Manpower Efficiency
Return on Medtronic PLC Manpower
Revenue Per Employee | 340.7K | |
Revenue Per Executive | 688.6M | |
Net Income Per Employee | 38.7K | |
Net Income Per Executive | 78.2M | |
Working Capital Per Employee | 117.3K | |
Working Capital Per Executive | 237.1M |
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.